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Summary The influence of anthracyclines on membrane permeability functions has been investigated in
HeLa cells by monitoring the efflux of fluorescein. Release of the fluorescent dye, dependent on the metabolic
energy supply, occurs after the intracellular accumulation and enzymatic hydrolysis of the non-fluorescent
substrate fluorescein diacetate (FDA). Flow cytometric evaluation of the efflux kinetics showed that
adriamycin (ADR), N-trifluoroacetyladriamycin-14-valerate (AD-32) and daunorubicin (DNR) inhibited the
permeability process. The degree of inhibition was dependent, though to different extent, on the intracellular
concentration of each drug. An increase in the efflux rate was always observed when the cells were treated
with the drugs in the presence of 20 mM glucose. Relationship of these effects with energetic metabolism was
supported by the finding that ATP levels were lowered by the drugs and increased by glucose. Evaluation of
the cytotoxicity induced by each drug showed that the intracellular amount necessary to inhibit cell survival
by 50% was of the same order of magnitude as that which decreases to 50% membrane permeability to
fluorescein. These results indicate a correspondence in the concentrations of anthracyclines required for
inducing cytotoxicity and for inhibiting membrane permeability functions dependent on the metabolic energy
supply.
Many studies have provided evidence that anthra-
cyclines interact with the cells at different sites,
such as DNA (Di Marco et al., 1974), membranes
(Goldman et al., 1978, Goormaghtigh and
Ruysschaert, 1984) and mitochondria (Gosalvez et
al., 1974; Ferrero et al., 1976; Mailer & Petering,
1976), however, it is not yet well understood to
what extent these interactions are involved in the
mechanisms that induce cytotoxicity.
Given the antitumoural activity shown by
derivatives that do not bind to DNA (Israel et al.,
1975; Krishan et al., 1976), or by polymer-bound
drugs that do not enter the cells (Tritton et al.,
1983; Rogers et al., 1983), particular attention has
been paid to the interaction with the cell
membrane. However, only a few studies have
attempted to investigate whether these drugs signifi-
cantly impair the membrane functions in intact cells
(Landolph et al., 1980; Murphree et al., 1981;
Chahwala & Hickman, 1985).
In a previous study we showed that daunorubicin
(DNR) was able to affect membrane permeability
properties determining the process of fluoro-
chromasia in living cells (Prosperi et al., 1985). This
process is based on the intracellular accumulation
and enzymatic turnover of a fluorogenic substrate,
causing the cells to become strongly fluorescent
(Rotman & Papermaster, 1966).
Fluorochromasia has been used to assess
membrane properties since the appearance of
fluorescence in the cells, resulting from enzyme
activity, depends on substrate influx and fluorescent
product efflux (Sengbush et al., 1976; Sontag, 1977;
Baisch, 1978; Augsten & Strauss, 1984). In parti-
cular, when fluorescein diacetate (FDA) is used as
the fluorogenic substrate, the efflux of the
fluorescent product (fluorescein) has been shown to
be influenced by membrane integrity (Rotman &
Papermaster, 1966), inhibited by mitochondrial
poisons and modulated by the presence or absence
of glucose in the extracellular medium (Prosperi et
al., 1986).). Therefore, the monitoring of the
kinetics of fluorescence decrease in fluorescein-
loaded cells may provide useful information on
membrane functions, especially on permeability
properties dependent on the metabolic energy
supply.
The efflux of fluorescein has been found to be
inhibited by DNR - an effect that is partially offset
by the presence of glucose - like the influence
exterted by mitochondrial poisons.
In order to further establish the actual role of
anthracyclines as agents that affect membrane
permeability functions, we investigated the influence
of other derivatives, as compared with that of
DNR. Adriamycin (ADR) and N-trifluoro-
acetyladriamycin-14-valerate (AD-32) were con-
sidered: the former - the anthracycline most often
used - is thought to exert its activity mainly by
DNA interaction (Di Marco et al., 1974), while the
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latter is characterized by an antitumoural activity
not involving DNA intercalation (Israel et al.,
1975). The ability of these drugs to inhibit fluore-
scein efflux and the dependence on metabolic
aspects were assessed by evaluating dye release in
the presence of glucose and by determining intra-
cellular ATP levels after drug treatments. The
relationship between the amount of drug taken up
and the degree of efflux inhibition was studied,
both in the presence and in the absence of glucose.
Indeed, it is known that the intracellular amount of
drug depends on the metabolic energy supply
(Dan0, 1973; Inaba et al., 1979). The cytotoxicity
induced by the drugs in the same conditions that
were found to inhibit the efflux of fluorescein was
also studied.
Materials and methods
Cells
HeLa cells were grown as monolayers in Corning
flasks in MEM (minimum essential medium),
supplemented by non-essential aminoacids, anti-
biotics and 10% foetal calf serum (Flow
Laboratories, Irvine, Ayrshire, U.K.). Twenty-four
hours after incubation, the cells were detached
following the standard trypsinization procedure and
suspended in MEM for suspension cultures, supple-
mented by antibiotics and 10% foetal calf serum. In
all the experiments, the cells were used 6h after
suspension.
Drugs and treatments
DNR, ADR and AD-32 were obtained from
Farmitalia C. Erba (Milan, Italy). Anthracyclines
were dissolved immediately before use in bidistilled
water, except for AD-32, which was prepared as
stock solution in dimethylsulphoxyde. Dilutions
were made in PBS at final concentrations ranging
from 0 to 17gM. The cells were washed from the
culture medium with PBS and incubated in the
drug solutions for 15min at 37°C, at a cell density
of 106ml-1. At the end of treatments, the cell
suspension was divided into aliquots for the
evaluation ofdrug uptake, or fluorescein efflux.
Preincubation with glucose was required when
studying the dependence of fluorescein efflux on the
metabolic energy supply. In order to avoid a
further step between drug treatment and efflux,
glucose (C. Erba, Milan, Italy) was added directly
to the drug solutions at the final concentration of
20mM.
Cytotoxicity experiments
Cells were seeded at a density of 2 x I05 cells ml-'
in 6-well Costar tissue culture cluster (Costar,
Cambridge, Mass. USA). Twenty-four hours later,
the cells were treated with the drugs for 15min,
then washed with PBS and incubated in drug-free
medium for 72h. At the end of this period the cells
adherent to the plate were harvested with trypsin
and counted in a Coulter Counter (Coulter
Electronics, Luton, UK). Cytotoxicity was
expressed as the number of cells with respect to the
control. The very low percentage (3-5%) of cells
still adherent but already dead (evaluated by trypan
blue dye exclusion test) did not alter significantly
the results.
Fluorescein efflux
FDA (Sigma, St Louis, USA) was prepared as the
stock solution at 5mgml-1 in acetone, and diluted
prior to use in PBS. Cell loading with fluorescein
was achieved by 5min incubation in 2.4pM FDA
solution at 37°C. The cells were thereafter
centrifuged and suspended in fresh PBS, after
removal of the supernatant. One aliquot of cell
suspension was measured immediately as the 'zero
time' sample, while the remaining cells were kept
under continuous shaking in a thermostated water
bath at 23°C, and measured at preset times.
Glucose was also added to the efflux medium when
present during drug treatments.
Fluorescence measurements were performed by
means of Leitz (Wetzlar, West Germany) micro-
scope-based flow cytometer (Steen & Lindmo,
1979). Excitation light, supplied by a mercury lamp
HBO 100W, was selected by an interference filter
450-490nm, and a chromatic beam splitter at
495nm. Fluorescence emission was collected with a
barrier filter at 510nm. The electrical pulses from
the photomultiplier were processed and memorized
by a spectrascope Modular 8000 (Laben, Milan,
Italy) multichannel analyzer and displayed as a
frequency distribution of fluorescence intensity.
Approximately 3 x 104 cells were measured from
each sample. To obtain the efflux time course, the
maximum fluorescence intensity from each histo-
gram was plotted versus time. Efflux rate constants
were calculated from the slopes of the curves by
regression analysis and found to be consistent with
a first-order kinetics (Rotman & Papermaster,
1966). Rate constant did not show significant
variations whether using a FDA concentration of
1.2gM, 2,4,uM or 4.8 gM.
The contribution of anthracycline fluorescence to
measurements was negligible in our experimental
conditions. Reabsorption or fluorescence energy
transfer from fluorescein to anthracyclines were
already considered (Prosperi et al., 1985): these
phenomena did not occur to any significant extent,ANTHRACYCLINE INHIBITION OF MEMBRANE FUNCTIONS
given the low absorption coefficient of anthra-
cyclines in the region where partial overlap with
fluorescein emission occurs, and the low quantum
yield of anthracyclines.
ATP determinations
ATP was determined by using the luciferine-
luciferase method (Boehringer, Mannheim, West
Germany), according to Wiener et al. (1974). After
drug treatments the cells were washed with PBS,
centrifuged and resuspended in ice-cold 0.6 M
perchloric acid; after 10min, the extracts were
neutralized with KOH. Luminescence measurements
were performed in the cuvette holder of a
fluorometer equipped with a single-photon counting
system (Ortec, Oak Ridge, USA). Instrument was
calibrated with ATP standard solutions.
Drug uptake
After incubation with the drugs, the cells were
centrifuged at 200g for 3min at room temperature,
and the medium was removed. The cell pellets were
resuspended in 1 ml of distilled water, subjected to
freezing and thawing, and lysed by a Branson
sonicator (Branson Europa N.V., The Netherlands).
50pl of cell lysate were removed for determination
of protein content (Lowry et al., 1951) and to the
rest 0.95ml of n-butanol was added. The samples
were vigorously shaken for 3min, and the organic
phase was collected after centrifugation at 200g for
10min. Fluorometric measurements of the extracts
were performed by means of a spectrofluorometer
(Applied Photophysics Ltd., UK) at an excitation
wavelength of 480nm, 496nm and 491 nm for
ADR, DNR and AD-32 respectively; emission
wavelength was set at 580nm for ADR and DNR,
and at 593 nm for AD-32. The experimental uptake
values were corrected by a factor calculated for
each drug, by determining the fluorescence intensity
ratio of a given amount of anthracycline dissolved
in n-butanol to the value measured after extraction
of a lysate-buffer solution containing the same
amount of drug. The extraction efficiences were
67%, 81% and 88% for ADR, DNR and AD-32
respectively.
Results
Figure 1 shows the distribution of fluorescence
intensity in drug-treated cells, as compared with
cells killed by thermal shock. The two histograms
appear significantly different: all the treated cells (a)
showed accumulation of fluorescein, while the dead
cells (b) did not. The occurrence of fluorochromasia
indicated that treatment of HeLa cells with ADR
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Figure 1 Fluorescence intensity histograms of HeLa
cells incubated for 5mm in 2.4jim FDA, after drug
treatment (a) or thermal shock (b).
or AD-32 did not induce, in our experimental
conditions, any significant loss of cell viability, at
the moment when the efflux measurements were
performed. Figure 2 shows examples of the time
course of fluorescein efflux from control and cells
treated with ADR and AD-32, after loading with
2.4pM FDA. In all the experiments, the efflux
followed first-order kinetics; therefore, the rate
constant of the process was considered to be a
suitable parameter for evaluating the extent of
anthracycline influence on membrane permeability
to fluorescein. The decrease in the efflux rate
induced by the drugs, was not significantly different
when the cells were loaded with fluorescein by
using different FDA concentrations. Cells treated
with 6,iM ADR, for instance, showed a rate
constant of 1.82x 10-4 (±0.52) s-', when
incubated with 2.4pM FDA, versus a constant of
1.65 x 10-4 (±0.56) s-1, when incubated in 4.8 M
FDA.
When glucose was added to the medium, an
increase in the efflux rate was observed, both in
control and in treated cells, as shown by the rate
constants given in Table I. Taking as the 100%
value the rate constant of control cells incubated
without glucose, the increase measured was 45% in
control cells, 44% and 33% in ADR and AD-32-
treated cells, respectively.
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Figure 2 Time course of fluorescein efflux in treated
and untreated HeLa cells. Control (0), ADR 2.5pM
(@), 17.2pM (*); AD-32 1.3pM (-). The
fluorescence intensity of each sample was normalized
to the value measured at zero time.
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Table I Influence of glucose on fluorescein efflux rate
(23°C) in control and drug-treated HeLa cells.
Rate constant
(s- ) Xl0-O
Sample n mean value+s.d. %
Control 10 3.50+0.51 100
Control 3 5.06+0.20 145a
+glucose 20mM
ADR 17.2pM 3 0.66+0.23 19
ADR 17.2,UM 3 2.21 +0.53 63a
+glucose 20mM
AD-32 1.3,UM 3 1.43+0.49 41
AD-32 1.3pM 3 2.58+0.29 74a
+glucose 20mM
aStudent's t test: P<0.01
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Figure 3 Dependence of fluorescein efflux rate on
drug uptake. The intracellular amount of drug was
evaluated in HeLa cells treated for 15min with: (a)
ADR (@), ADR+20mM glucose (0); (b) DNR (A),
DNR+20mM glucose (II); (c) AD-32 (A), AD-
32+20mM glucose (A). Data points are from at least
3 different experiments. For control cells incubated
with or without glucose the mean values of 3 and 10
experiments respectively, are reported. Fitted lines
were calculated by regression analysis.
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Figure 3 shows the dependence of the efflux rate
on the drug uptake in cells treated with or without
glucose. Both conditions were evaluated, since the
addition of glucose in the incubation medium might
have induced a further export of the drugs from the
cells. For each drug, at a given intracellular
concentration, the presence of glucose induced an
increase in the rate constant, without any appreci-
able difference in the trend of the curve. In the
range of concentration tested, the efflux rate
constant decreased linearly as the amount of intra-
cellular drug increased in ADR-treated cells (a). In
DNR-treated cells (b), two different slopes were
found: the faster decrease was observed up to an
intracellular concentration of - 0.1 nmol mg - 1
protein. For AD-32 (c), an exponential relationship
seems to fit. The greatest inhibition of the efflux
was exerted by DNR: the amount that induced a
50% decrease in the efflux rate (0.59nmolmg- 1
protein) was lower than that found for ADR and
for AD-32 (0.67 and 2.77nmolmg-t protein,
respectively).
Determinations of ATP levels in cells treated
with anthracyclines showed that the considered
drugs reduced ATP content with respect to
control cells and that glucose increased all the
values of both treated and control cells. Table II
reports ATP levels in cells treated with ADR, DNR
and AD-32 at the concentrations that inhibit
fluorescein efflux by 50% in respect to the control,
both in the presence and in the absence of glucose
20 mM.
The extent of cytotoxicity induced by ADR, AD-
32 and DNR in HeLa cells was determined at the
same drug concentrations that inhibited the fluore-
scein efflux. Figure 4 shows the surviving fractions
of cells treated for 15min with ADR (a), DNR (b)
and AD-32 (c), as a function of drug availability in
the medium. The insert in each panel also shows
the amounts of drug taken up by the cells in the
same experiments. These data indicate that ADR
showed the highest activity: the 50% inhibition of
cell proliferation was found at 0.37nmolmg- 1
protein for ADR, 0.64 for DNR and 1.40 for AD-32.
Discussion
The efflux of fluorescein from living cells has been
shown to be dependent on membrane integrity and
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Figure 4 HeLa cell survival at 72h after treatment
with ADR (a), DNR (b), and AD-32 (c), plotted
versus drug concentration in the medium. In the insert
of each panel it is shown the amount of drug taken up
as a function of concentration in the medium.
Table II ATP levels in HeLa cells treated with anthracyclines in the presence or
in the absence of glucose.
Without glucose With glucose
nmol ATPmg -protein nmol ATPmg1 protein
mean value +s.d. mean value +s.d.
(n=5) % (n=5) %
Control 7.64+0.02 100 13.24+0.60 100
ADR 6gM 5.50+0.88 72 10.40+0.22 79
DNR 1IuM 4.78+0.37 62 11.86+1.25 89
AD-32 4pM 4.65+0.75 61 8.16+1.97 61
I~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
.1948 A.C. CROCE et al.
on the metabolic energy supply; indeed, the dye
release is affected both by membrane-active agents
and mitochondrial poisons (Sengbush et al., 1976;
Baisch, 1978; Prosperi et al., 1986). Therefore, the
monitoring of the kinetics of fluorescence decrease
from anthracycline-treated cells may provide
information on alterations induced by the drugs,
either on membrane structures or energetic cell
metabolism. These two aspects can be
distinguished, since only the effect on metabolism is
offset by glucose.
The anthracyclines considered inhibited fluorescein
efflux apparently through the same mechanism
shown by metabolic inhibitors, since glucose was
able to restore the efflux. This restoration might
have been induced by a lower drug accumulation,
since anthracyclines are also actively exported from
the cells (Dan0, 1973; Inaba et al., 1979). However,
this possibility is ruled out by the finding that, at
the same intracellular amount of drug, fluorescein
efflux measured in the presence of glucose was
always faster than that in cell incubated without
glucose (Figure 3). This increase was also observed
in cells incubated without drug, thus suggesting
that glucose increases energy levels available for
efflux. This hypothesis is supported by the finding
that drug treatments also induced a reduction of
the ATP levels into the cells. Concurrently, glucose
was able to increase energy availability, both in
treated and in control cells. Furthermore, the
possibility of an inhibition of fluorescein efflux
by a direct interference of anthracycline molecules,
seems rather unlikely since the rate constant of the
dye release did not change significantly when higher
levels of fluorescein were attained into the cells by
using different FDA concentrations. It appears
therefore that ADR, DNR and AD-32, irrespective
of their ability to bind to DNA, affected mem-
brane permeability functions dependent on the
metabolic energy supply, by impairing mito-
chondrial activity. Interactions at the mitochondrial
level, resulting in impaired metabolic reactions
have been already observed by several authors
(Gosalvez et al., 1974; Iwamoto et al., 1974;
Ferrero et al., 1976; Mailer & Petering, 1976;
Folkers etal., 1977; Goormaghtigh etal., 1982; Solaini
et al., 1985) and our findings are consistent
with these reports.
The anthracyclines investigated in this study
showed a different ability in inhibiting fluorescein
efflux. In particular, AD-32 was at least 4 times less
effective than DNR and ADR, when the rate
constant was related to the amount of drug
accumulated intracellularly. These results could be
explained by taking into consideration a possible
differential affinity of the drugs for mitochondrial
structures. Indeed, binding to cellular compart-
ments is greatly established by the charged form of
the anthracyclines, that are protonated in the
amino group of the sugar moiety (Skovsgaard &
Nissen, 1982; Siegfried et al., 1985). AD-32 is less
ionizable than DNR and ADR, due to the
substitution of an hydrogen with a -COCF3 group
in the amino residue; therefore, it is possible that
mitochondrial uptake, that could be also driven,
like other cationic dyes (Johnson et al., 1981;
Lampidis et al., 1983), by the inside-negative
potential of mitochondrial membrane, is lower for
the uncharged form of the drugs. Furthermore, it is
known that ionized anthracyclines interact with
negatively charged phospholipids (i.e. cardiolipin,
Goormaghtigh et al., 1980) thereby impairing the
cytochrome c oxidase activity (Goormaghtigh et al.,
1982). These arguments may account both for the
qualitative and quantitative differences found for
the relationship between fluorescein efflux rate and
intracellular amount of drug.
Although many reports support an interaction of
anthracyclines with energetic metabolism, the actual
contribution of these interactions to cytotoxicity is
not yet known, nor the relationship between cyto-
toxicity and changes in membrance functions has
been studied extensively. A correspondence of ADR
doses required both for cytotoxicity and changes in
the rate of lectin-induced cellular agglutination has
been reported by Murphree et al. (1976); on the
other hand, inhibition of 86Rb uptake in confluent
fibroblasts has been shown to occur at concen-
trations two orders of magnitude higher than those
causing cytotoxicity (Landolph et al., 1980). In our
experiments, the same conditions that affected
permeability properties were also toxic to HeLa
cells. The cytotoxicity assay showed that for each
drug, the amount reducing cell survival to 50% was
in the same order of magnitude as that inhibiting
fluorescein efflux to the same degree. It is worth
noting that the effect on membrane permeability was
assessed immediately, while the cells were still
viable. Cytotoxicity was, on the contrary, evaluated
72h later, when interaction with other cellular
targets, the metabolic fate of the drugs, as well as,
possibly, recovery of the cells had potentially
occurred. These findings suggest a further study on
fluorescein efflux evaluated at different times after
drug treatment, in relation to other cellular
parameters as ATP content and cell cycle
distribution, in order to better clarify to what
extent modification of these factors contributes to
anthracycline cytotoxicity.
We thank Mr. G. Michelazzo for drawings and
photographic work, and Miss A. Ganassa for typing the
manuscript. Work supported by C.N.R., Special Project
'Oncology'.ANTHRACYCLINE INHIBITION OF MEMBRANE FUNCTIONS 949
References
AUGSTEN, K. & STRAUSS, D.G. (1984). The effects of
violamycins on the cell membranes of murine
macrophages and L 1210 tumour cells in vivo. Studia
Biophysica, 104, 219.
BAISCH, H. (1978). Effects of X-rays on cell membranes.
II. Changes of permeability measured by fluorescein
efflux. Rad. Environ. Biophys., 15, 221.
CHAHWALA, S.B. & HICKMAN, J.A. (1985). Investigations
of the action of the antitumor drug adriamycin on
tumour cell membrane function-I. Biochem.
Pharmacol., 34, 1501.
DAN0, K. (1973). Active outward transport of
daunomycin in resistant Ehrlich ascite tumour cells.
Biochim. Biophys. Acta, 323, 466.
DI MARCO, A., ARCAMONE, F. & ZUNINO, F. (1974).
Daunomycin (daunorubicin) and adriamycin and
structural analogues: biological activity and
mechanism of action. In Antibiotics, (eds) Corcoran, J.
and Hahnm, F.E., Vol. III, p. 101. Springer-Verlag:
Berlin, Heidelberg, New York.
FERRERO, M.E., FERRERO, E., GAJA, G. & BERNELLI-
ZAZZERA, A. (1976). Adriamycin energy metabolism
and mitochondrial oxidations in the heart of treated
rabbits. Biochem. Pharmacol., 25, 125.
FOLKERS, K., LIU, M., WATANABE, T. & PORTER, T.H.
(1977). Inhibition by adriamycin of the mitochondrial
biosynthesis of coenzyme Qlo and implication for the
cardiotoxicity of adriamycin in cancer patients.
Biochem. Biophys. Res. Commun., 77, 1536.
GOLDMAN, R., FACCHINETTI, T., BACH, D., RAZ, A. &
SHINITZKY, M. (1978). A differential interaction of
daunomycin, adriamycin and their derivatives with
human erythrocytes and phospholipids bilayers.
Biochim. Biophys. Acta, 512, 245.
GOORMAGHTIGH, E., BRASSEUR, R. & RUYSSCHAERT,
J.M. (1982). Adriamycin inactivates cytochrome c
oxidase by exclusion of the enzyme from its cardiolipin
essential environment. Biochem. Biophys. Res.
Commun., 104, 314.
GOORMAGHTIGH, E., CHATELAIN, P., CASPERS, J. &
RUYSSCHAERT, J.M. (1980). Evidence of a specific
complex between adriamycin and negatively-charged
phospholipids. Biochim. Biophys. Acta, 597, 1.
GOORMAGHTIGH, E. & RUYSSCHAERT, J. (1984).
Anthracycline glycoside-membrane interactions.
Biochim. Biophys. Acta, 779, 271.
GOSALVEZ, M., BLANCO, M., HUNTER, J., MIKO, M. &
CHANCE, B. (1974). Effects of anticancer agents on the
respiration of the isolated mitochondria and tumor
cells. Eur. J. Cancer, 10, 567.
INABA, M., KOBAYASHI, H., SAKURAI, Y. & JOHNSON,
K. (1979). Active efflux of daunorubicin and
adriamycin in sensitive and resistant sublines of P388
leukemia. Cancer Res., 39, 1365.
ISRAEL, M., MODEST, E.J. & FREI III, E. (1975). N-
trifluoroacetyladriamycin-14-valerate, an analog with
greater experimental antitumor activity and less
toxicity than adriamycin. Cancer Res., 35, 1365.
IWAMOTO, Y., HANSEN, I.L., PORTER, T.H. & FOLKERS,
K. (1974). Inhibition of coenzyme Q1o-enzymes,
succinoxidase and NADH-oxidase, by adriamycin and
other quinones having antitumor activity. Biochem.
Biophys. Res. Commun., 58, 633.
JOHNSON, L.W., WALSH, M.L., BOCKUS, B.J. & CHEN,
L.B. (1981). Monitoring of relative mitochondrial
membrane potential in living cells by fluorescence
microscopy. J. Cell Biol., 88, 526.
KRISHAN, A., ISRAEL, M., MODEST, E. & FREI III, E.
(1976). Differences in cellular uptake and cyto-
fluorescence of adriamycin and N-trifluoroacetyl-
adriamycin-14-valerate. Cancer Res., 36, 2108.
LAMPIDIS, T.J., BERNAL, S.D., SUMMERHAYES, I.C. &
CHEN, L.B. (1983). Selective toxicity of rhodamine 123
in carcinoma cells in vitro. Cancer Res., 43, 716.
LANDOLPH, J.R., BHATT, R.S., TELFER, N. &
HEIDELBERGER, C. (1980). Comparison on
adriamycin- and ouabain-induced cytotoxicity and
inhibition of 86rubidium transport in wild-type and
ouabain-resistant CEH/l0Tl/2 mouse fibroblasts.
Cancer Res., 40, 4581.
LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. &
RANDALL, R.J. (1951). Protein measurement with the
Folin phenol reagent. J. Biol. Chem., 193, 265.
MAILER, K. & PETERING, D.H. (1976). Inhibition of
oxidative phosphorylation in tumor cells and
mitochondria by daunomycin and adriamycin.
Biochem. Pharmacol., 25, 2085.
MURPHREE, S.A., CUNNINGHAM, L.S., HWANG, K.M. &
SARTORELLI, A.C. (1976). Effects of adriamycin on
surface properties of sarcoma 180 ascite cells. Biochem.
Pharmacol., 25, 1227.
MURPHREE, S.A., TRITTON, T.R., SMITH, P.L. &
SARTORELLI, A.C. (1981). Adriamycin-induced
changes in the surface membrane of Sarcoma 180
Ascites cell. Biochim. Biophys. Acta, 649, 317.
PROSPERI, E., CROCE, A.C., BOTTIROLI, G. & SUPINO, R.
(1985). Influence of daunorubicin on membrane
permeability properties: detection by means of intra-
cellular accumulation and efflux of fluorescein. Chem.-
Biol. Interactions, 54, 271.
PROSPERI, E., CROCE, A.C., BOTTIROLI, G. & SUPINO, R.
(1986). Flow cytometric analysis of membrane
permeability properties influencing intracellular
accumulation and efflux of fluorescein. Cytometry, 7,
70.
ROGERS, K.L., CARR, B.I. & TOKES, A. (1983). Cell
surface-mediated cytotoxicity of polymer-bound
adriamycin against drug-resistant hepatocytes. Cancer
Res., 43, 2741.
ROTMAN, B. & PAPERMASTER, B.W. (1966). Membrane
properties of living mammalian cells as studied by
enzymatic hydrolysis of fluorogenic esters. Proc. Natl.
Acad. Sci. USA., 55, 134.
SENGBUSH, G.V., COUWENBERGS, C., KONHER, J. &
MOLLER, U. (1976). Fluorogenic substrate turnover in
single living cells. Histochem. J., 8, 341.950 A.C. CROCE et al.
SIEGRIED, J.M., BURKE, T.M. & TRITTON, T.R. (1985).
Cellular transport of anthracyclines by passive
diffusion. Biochem. Pharmacol., 34, 593.
SKOVSGAARD, T. & NISSEN, N.I. (1982). Membrane
transport ofanthracyclines. Pharmac. Ther., 18, 293.
SOLAINI, G., RONCA, G. & BERTELLI, A. (1985).
Inhibitory effects of several anthracyclines on
mitochondrial respiration and coenzyme Q10
protection. Drugs Exptl. Clin. Res., 8, 533.
SONTAG, W. (1977). A comparative kinetic study on the
conversion of fluoresceindiacetate to fluorescein in
living cells and in vitro. Rad. Environ. Biophys., 14, 1.
STEEN, H.B. & LINDMO, T. (1979). Flow cytometry: a
high resolution instrument for everyone. Science, 204,
403.
TRITTON, T.R., YEE, G. & WINGARD, JR. L.B. (1983).
Immobilized adriamycin a tool for separating cell
surface from intracellular mechanism. Fed. Proc., 42,
284.
W1ENER, S., WIENER, R., URIVETZKY, M. & MEILMAN,
E. (1974). Coprecipitation of ATP with potassium
perchlorate: the effect on the firefly enzyme assay of
ATP in tissue and blood. Anal. Biochem., 59, 489.